Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.
Iterative Health develops technology that can benefit patients anywhere, regardless of socioeconomic or geographic barriers.
Grove Biopharma is a biotechnology company offering a materials science solution to peptide therapeutic challenges.
Trans Solutions Research and Resource Center empowers transgender and gender communities.
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases
Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.
Crossbow Therapeutics is a biotech company that develops targeted therapies to address cancer antigens.
Maxion Therapeutics helps in learning transformative therapies.
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Zephyr AI is a healthcare technology company that reshapes traditional approaches to drug discovery and precision medicine.
IgGenix is a biotechnology company.
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.
Arkuda Therapeutics is a pharmaceutical company.
Trogenix is a biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour.
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders
Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.
Syndeio Biosciences is a newly launched biotech company pioneering precision neurotherapeutics.
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.
Solu Therapeutics Platform Company that develops antibody-based medicines using a degradable warhead.
Persist AI is a biotechnology company that builds long-acting microsphere formulations.
Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.
Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.
Revisto is a pioneer AI-powered technology that simplifies the medical, legal, and regulatory review process for pharmaceutical marketing.
Eli Lilly has invested in 158 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Eli Lilly's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 20 different industry categories.
Among tracked funding rounds, Flare Therapeutics received $123.0M in a Series B round. Eli Lilly's total known invested capital is $7.3B.
Eli Lilly's average investment size is $55.2M across its portfolio of 158 companies.
Recent Eli Lilly portfolio additions include Incyclix Bio, Iterative Health, Grove Biopharma, Trans Solutions Research and Resource Center, Jaguar Gene Therapy. These companies were founded in 2020 or later.